Literature DB >> 8263784

Microdialysis study of zidovudine (AZT) transport in rat brain.

K H Dykstra1, A Arya, D M Arriola, P M Bungay, P F Morrison, R L Dedrick.   

Abstract

The concentration profiles of [14C]3'-azido-3'-deoxythymidine (AZT) emanating from an acutely implanted microdialysis probe were measured in rat caudate putamen by quantitative autoradiography for infusions of 14 min and 1 and 2 h. A mathematical model which simulated diffusive solute transport, unaffected by the processes of microvascular exchange or tissue metabolism, did not fit the observed concentration profiles. Chromatographic analysis of brain homogenates for metabolites of AZT showed that the rate of metabolic transformation was not large enough to affect transport of the drug through the brain tissue. A model simulating the effect of microvascular exchange on the diffusion profiles fit the observed concentration profiles and the transient change in the dialysate extraction fraction. This analysis yielded an estimated tissue elimination rate constant for microvascular exchange of Kel = 0.013 ml/(g.min) and an intra- to extracellular partition coefficient of K pi = 1.04. Inclusion of probenecid in the dialysate, together with an i.p. injection, led to a substantial increase in the diffusion distance of the labeled AZT from the microdialysis probe, suggesting at least a 4-fold decrease in the microvascular exchange rate constant. These results imply that AZT is actively transported out of the brain parenchyma to the microvasculature and that this active transport mechanism is responsible for the limited central nervous system penetration of systemically administered AZT, in spite of its high lipid solubility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263784

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Probe calibration in transient microdialysis in vivo.

Authors:  P M Bungay; R L Dedrick; E Fox; F M Balis
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 2.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Alzheimer's disease drug development and the problem of the blood-brain barrier.

Authors:  William M Pardridge
Journal:  Alzheimers Dement       Date:  2009-09       Impact factor: 21.566

5.  Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method.

Authors:  M Hammarlund-Udenaes; L K Paalzow; E C de Lange
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

Review 6.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

7.  The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach.

Authors:  Y Wang; D F Welty
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 8.  Distribution of drugs following controlled delivery to the brain interstitium.

Authors:  M Mak; L Fung; J F Strasser; W M Saltzman
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

9.  Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis.

Authors:  Y Deguchi; K Inabe; K Tomiyasu; K Nozawa; S Yamada; R Kimura
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

10.  Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.